Notícias CytomX Therapeutics Inc - CTMX | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
CytomX Therapeutics Inc (CTMX)
CytomX Therapeutics Inc (CTMX) Notícias

CytomX Therapeutics Inc (CTMX)

0,85

-0,025

(-2,86%)

Fechado 02 Fevereiro 6:00PM

Atrasado por 15 minutos

0,87

0,02

(2,35%)

Após o horário de negociação: 8:01PM

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Form 8-K - Current report

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

CytomX Therapeutics to Present at Upcoming September Investor Conferences

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

CytomX Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições